Practice Area

Biotechnology

Publications

June 15, 2017 High Court Interprets The Biosimilars Statute — What Now?

June 6, 2017 Update on Biosimilar Approvals and Pending Applications in Europe and the U.S.

April 27, 2016 A Breakthrough Technology is Caught in an Epic Patent Battle

March 16, 2016 Biosimilar Makers Turn To IPRs Despite Mixed Results

December 9, 2015 All Camps Agree: Memorable Biosimilar Names are a Must

October 27, 2015 TPP Biologics Exclusivity Period Maintains The Status Quo

June 2015 Biobetters: The Advantages and Challenges of Being Better

June 2015 New Targets in the Crosshairs: A forum to invalidate patents is now being used on biotech firms

April 2015 The Value of Being Highly Similar: First U.S. Biosimilar

October 2014 If High Court Reverses Teva, Litigation Costs May Increase

February 2012 FDA Issues Draft Guidelines for Biosimilars

June 2011 Supreme Court Decision: Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.